www.Top100Pharmacy.com - TOP 100 PHARMACY SITES
TOP 100 PHARMACY SITES
 Main  |  Add a Site  |  FREE Content for Your Web-site  |  Bookmark this site  |  Links  |  Webmaster 
Updated Mon, June 16, 2008.
51.medlibrary.org49900
52.PHRMA - Home...">www.phrma.org49900
53.www.krka.si49200
54.www.sanofi-aventis.com47800
55.www.ventanamed.com47700
56.www.novonordisk.com44900
57.www.drugresearcher.com44700
58.www.blessedherbs.com44700
59.www.healthsquare.com44300
60.www.pharmcast.com43400
61.www.eisai.co.jp43200
62.www.boehringer-ingelheim.com43000
63.www.aacp.org42800
64.www.spine-health.com42400
65.www.pharmaceuticalonline.com41900
66.www.solvay.com41100
67.www.laegemiddelstyrelsen.dk40700
68.www.hexal.de40500
69.medshopexpress.com38800
70.emc.medicines.org.uk38700
71.www.rpsgb.org.uk38100
72.www.zymogenetics.com38100
73.www.baxter.com37700
74.www.aidsinfo.nih.gov37600
75.www.banyu.co.jp36800
76.www.cardiovascularpharm.com36400
77.www.bago.com36400
78.www.cancerbacup.org.uk36200
79.www.cardinal.com36100
80.www.bausch.com35900
81.www.jandrugs.com35500
82.www.ismp.org35400
83.www.psychopharmacology.com35100
84.www.diahome.org34200
85.www.controlled-trials.com34100
86.www.needymeds.com34000
87.www.stada.de33900
88.www.genzyme.com33600
89.www.infomed.org33400
90.www.legemiddelverket.no33000
91.www.akzonobel.com32900
92.www.schering-plough.com32800
93.www.recipe.ru32500
94.www.clinicaltrialssearch.org32300
95.www.viagra.com32200
96.www.pharmiweb.com31300
97.www.mdli.com31100
98.www.solvay-pharma.ru30800
99.www.biopsychiatry.com30400
100.www.farmacie.it30300
Pages:  1  2  3  4  5  6  7  8  9  10 


Subscribe to RSS feed Subscribe to Feed Burner feed Add to Del.icio.us Add to Yahoo Add to Google Add to Furl Add to Reddit Add to Blink Add to Meneame Add to Fark Add to Ma.gnolia Add to Newsvine Add to Shadows

80. www.bausch.com

Rating: 35900 points*
*amount mentions of word 'www.bausch.com' on the other websites

www.bausch.com

Bausch & Lomb, Inc. Official Home Page

Description: Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life®. We offer the world’s most comprehensive portfolio of eye health products and we’re proud that ours is one of the oldest, best known and most respected healthcare brands in the world.

Most popular searches: wwwbausch.com, ReNu no rub, ReNu Multi-Plus Solution, ww.bausch.com, vision, wwwb.ausch.com, www.baush.com, www.baushc.com, ReNu rewetting, Sensitive Eyes, Optima FW contact lenses, LASIK, www.busch.com, SofLens Multi-Focal contact lenses, SofLens disposable contact lenses, SofLens66 contact lenses, www.bausch.om, www.ausch.com, www.bauch.com, www.bausch.cmo, age-related macular degeneration, Boston GP contact lenses, eyes, www.bausch, contact lenses, ww.bausch.com, www.basch.com, eye, contact lens solutions, www.bausch.ocm, www.buasch.com, www.baucsh.com, ww.wbausch.com, Ocuvite PreserVision eye vitamins, www.bausch.cm, www.bausch.co, www.bauschcom, www.bausch.com, www.abusch.com, www.bausc.com, www.bausc.hcom, wwwbausch.com, PureVision, www.bauschc.om, macular degeneration, SofLens66 Toric contact lenses, www.basuch.com

Google

© 2005-2008 www.Top100Pharmacy.com
Turn to generics slows ‘07 health care spending
Spending on health care slowed slightly in 2007 as consumers turned more to generic drugs instead of brand-names to fill their medicine cabinets, the government reported.
msnbc.msn.com
Health secretary presses lawmakers on reform
The Health and Human Services Secretary told lawmakers that President Obama is open to suggestions on how to pay for a health care overhaul, as long as they don't increase the deficit.
msnbc.msn.com
E.U. Warns Drugmakers on Blocking Generics
The European antitrust regulators told pharmaceutical companies that they could face tighter scrutiny and steeper fines for keeping generic drugs from consumers.
nytimes.com
Plan for Kidney Drugs Spurs Division
A plan to help pay for the drugs that transplant recipients need has run into opposition from dialysis providers, drug companies and the National Kidney Foundation.
nytimes.com
Pfizer Acquires a Stem-Cell Therapy
Pfizer will have the rights to develop Athersys’s cells to treat inflammatory bowel disease, which is in early human testing.
nytimes.com